3-Methoxyazetidine hydrochloride → (3-Methoxy-azetidin-1-yl)-[6-(5-methyl-3-phenyl-isoxazol-4-ylmethoxy)-pyridin-3-yl]-methanone

HRID 331955Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 331955
[CH3:1][C:2]1[O:6][N:5]=[C:4]([C:7]2[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=2)[C:3]=1[CH2:13][O:14][C:15]1[CH:23]=[CH:22][C:18]([C:19]([OH:21])=O)=[CH:17][N:16]=1.Cl.[CH3:25][O:26][CH:27]1[CH2:30][NH:29][CH2:28]1>>[CH3:25][O:26][CH:27]1[CH2:30][N:29]([C:19]([C:18]2[CH:17]=[N:16][C:15]([O:14][CH2:13][C:3]3[C:4]([C:7]4[CH:8]=[CH:9][CH:10]=[CH:11][CH:12]=4)=[N:5][O:6][C:2]=3[CH3:1])=[CH:23][CH:22]=2)=[O:21])[CH2:28]1

Komponenten

3

Versuchsvorschrift

As described for example 8b, 6-(5-methyl-3-phenyl-isoxazol-4-ylmethoxy)-nicotinic acid (100 mg, 0.32 mmol) was converted, using 3-methoxyazetidine hydrochloride instead of methylamine, to the title compound (75 mg, 61%) which was obtained as a light yellow oil. MS: m/e=380.3 [M+H]+.

Quellen und Nachweise

ORD-Eintrag
ord-f8838895f32f4529bc33c523921b5bac
Quelldatensatz
uspto-grants-2014_11
Patentnummer
US08877782B2

Notizen zur Reaktion

Wird geladen…